TBT WTO Indonesia
Home
Regulation
Notification
FAQ
Forum
Contact Us
Login
Logout Confirmation
Apakah anda yakin
Notification Detail :: G/TBT/N/CAN/725/Add.1
Main Data
Notification No.
Notification Type
Notifying Member
Date of Notification
Final Date for Comments
Days to Final Date
Title
Supplementary Rules Respecting Nicotine Replacement Therapies Order
Objective
Other (TBT)
Product Covered
Medicaments ICS:11.120.10
Document Notification
Link to ePing
HSCODE
ICSCODE
11.120.10 - Medicaments; 11.120.10 - Medicaments
Keywords
Human health; Human health
Specific Regions
Additional Data
Description
The Supplementary Rules Respecting Nicotine Replacement Therapies Order (this Order) applies to nicotine replacement therapies (NRTs)s for administration in the oral cavity that are regulated under the Natural Health Products Regulations for use in smoking cessation by adults who smoke. This Order introduces new measures that: Incorporate by reference the List of Nicotine Replacement Therapy Dosage Forms that may be Accessible for Self-selection by Purchasers or Consumers (the List); Prohibit direct public access to dosage forms of NRTs that have a limited history of appropriate use, which are not on the List, by requiring that they be sold by a pharmacist or someone under their supervision and are otherwise inaccessible for self-selection;Require warnings about the addictive nature of nicotine and statements conveying the intended subpopulation (i.e., individuals 18 years of age or older) on product labels and in advertisements;Restrict advertising and promotion that could be appealing to young people or if they convey a use other than the product’s intended use (i.e., smoking cessation); Restrict packaging and labelling that could be appealing to young people; andProhibit persons from manufacturing or selling NRTs that are in certain flavours as outlined in the Order.The Order comes into force immediately upon publication. At this time, NRTs must not be manufactured or sold unless they are compliant with the flavour restrictions set out in the Order and NRTs in dosage forms not on the List must not be sold on a retail basis except by a pharmacist or an individual working under the supervision of a pharmacist. The Order provides a six-month transition period to come into compliance with requirements of the Order that relate to packaging and labelling, and advertising and promotion. In addition, the Order provides for the sale of an NRT that is not labelled or packaged in accordance with the Order if it was labelled prior to the coming into force of the Order, or, if the NRT was imported, it was imported and labelled in accordance with the Natural Health Products Regulations prior to the coming into force of the Order.
Notified Document
1:
File here
2:
File here
Link to Notification
EN:
File here
FR:
File here
Status Active
Active
Inactive
Comment
No
#
Comment By
Title
Comment Date
File
Back
Link to ePing
App Settings
Dark Mode
NEW
Adjust the appearance to reduce glare and give your eyes a break.
Header Inverse
Sidebar Fixed
Sidebar Grid